Search

Search Constraints

You searched for: Author/Creator Clemens, Eva

Search Results

1. Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects study. (December 2016)

3. Hearing loss after platinum treatment is irreversible in noncranial irradiated childhood cancer survivors. (17th February 2017)

4. PanCareLIFE: The scientific basis for a European project to improve long-term care regarding fertility, ototoxicity and health-related quality of life after cancer occurring among children and adolescents. (November 2018)

5. Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function. Issue 4 (14th February 2021)

6. Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium. Issue 1 (January 2019)

7. Risk factors associated with tinnitus in 2948 Dutch survivors of childhood cancer: a Dutch LATER questionnaire study. Issue 1 (15th September 2020)

8. The cumulative incidence of cisplatin‐induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessments. Issue 1 (7th September 2021)

10. Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study. (October 2020)